Christine Blank

More than 150 pharmacy stakeholder organizations - including drug chains such as Walgreens - support a Centers for Medicare and Medicaid Services’ proposal that would eliminate direct and indirect remuneration (DIR) fees.

Rounding up the news you need to know to start the new year.

Pharmacists retain their spot in third place among trusted professions because of their attention to customers.

From retail to hospital, new group provides networking opportunities, professional guidance, and personal support to women pharmacists nationwide.

Pharmacy competition is driving the development of innovative savings and loyalty programs to increase traffic and secure clientele.

Failure to comply with CVS' robbery protocols resulted in dismissals.

CVS vs Amazon, Naxolone, and more. 

CVS health care defended itself after the drugstore chain and Walgreens were added to a Florida lawsuit alleging that they failed to stop suspicious opioid prescriptions.

Small Doses is back, bringing pharmacists the latest clinical and professional news you missed this month.

After a bad 2017 season, pharmacies and the FDA are pushing the public to still get flu vaccines.

October is American Pharmacists Month-here's how you can get involved.

A new FDA plan will offer new education opportunities for a variety of healthcare workers.

The September Small Doses brings you the latest news that affects pharmacists.

The EpiPen shortage is putting lives at risk and creating a back-up at some pharmacies. But solutions are on the horizon.

Small Doses is back, bringing you the pharmacy news you need in a way that works for you.

The drug is the first approved under the agency's new, quicker generic approval designation.

A Kentucky pharmacy owner was recently accused of making custom pain pills for pill mills.

Express Scripts expands its prescription kiosk sites.

Opioid shortages have hit hospitals all over the country.

A reversal agent to stop serious bleeding in patients treated with apixaban and rivaroxaban has been approved.

Oral rivaroxaban may be preferable to injections of low-molecular-weight heparins for patients being treated for cancer.

Easy-to-swallow bits of news from the past month, tailored for the busy pharmacist.

In one recent example, a pharmacist tackled the robber-but was that the right move?

NACDS is welcoming a recent bill mandating e-prescribing.

ASHP predicts leadership changes, enlarged roles for pharmacists, and financial pressures.

Both Pfizer and Teva have brought out generic versions of Viagra, a boon to the millions of men with erectile dysfunction.